コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 to manganese is an environmental risk factor for neurologic disorders, such as a Parkinson's disease-like syndrome known
2 on are two approaches for weakening maladaptive memories in disorders such as addiction and post-traumatic stress disorde
3 potential of ALD for the prevention/treatment of inner ear disorders such as age-related hearing loss.
5 The global burden of disease attributable to externalizing disorders such as alcohol misuse calls urgently for effective
6 suggest that the key proteins involved in neurodegenerative disorders such as alpha-synuclein and tau, might also play a
9 developmental language disorder, dyslexia, and motor-speech disorders such as articulation disorder and stuttering.
10 nterleukin-33 (IL-33) plays an important role in refractory disorders such as asthma, allergic rhinitis and food allergy,
11 y, and its disruption has been linked to neurodevelopmental disorders such as autism and schizophrenia.
12 ic violation, implying that any application to heterogenous disorders such as autism spectrum disorder will require indiv
13 ndings have implications for the management of neurological disorders, such as autism and intellectual disability, that a
14 neuronal development is frequently impaired in neurological disorders, such as autism and schizophrenia.
15 normal growth and development and is dysregulated in human disorders such as benign overgrowth syndromes, cancer, primar
17 s, and Parkinson's disease, peripheral nervous system (PNS) disorders such as chemotherapy-induced, diabetic, and inherit
18 d may offer an improved treatment option for keratinization disorders such as congenital ichthyosis and Darier disease.
20 nucleus accumbens has been argued to underlie motivational disorders such as depression, and many prominent theories of
22 omeres are a principal defining feature of telomere biology disorders, such as dyskeratosis congenita (DC), for which the
25 ad is a relatively common clinical condition resulting from disorders such as hereditary hemochromatosis, thalassemia, si
26 Uteroplacental hypoxia is associated with pregnancy disorders such as intrauterine growth restriction and preecla
27 nal (GI) pain - a form of visceral pain - is common in some disorders, such as irritable bowel syndrome, Crohn's disease
28 This work has wider implications for disorders, such as multiple sclerosis and CNS injury.SIGNIFIC
29 Patients with sialidosis present various neurological disorders such as: myoclonic epilepsy and hypotonia, often as
30 o novel therapeutic approaches to metabolic and age-related disorders such as osteoporosis and diabetes mellitus.
32 ses, and its disruption is implicated in neurodevelopmental disorders such as Phelan-McDermid syndrome, autism spectrum d
33 SULT4A1 has been implicated in several neuropsychiatric disorders, such as Phelan-McDermid syndrome and schizophrenia
34 Aversive memories are at the heart of psychiatric disorders such as phobias and post-traumatic stress disorder
35 role of BDNF in vulnerability to stress and stress-related disorders, such as posttraumatic stress disorder (PTSD), is a
36 ork may lead to improved diagnosis and treatment for stress disorders such as PTSD, that result in decreased quality of l
40 sociation cortices are particularly vulnerable in cognitive disorders such as schizophrenia and Alzheimer's disease, whil
41 As a result, D2R is involved in the pathophysiology of disorders such as schizophrenia and drug addiction.
42 neurons may represent a novel target for pharmacotherapy in disorders such as schizophrenia which involve aberrant increa
43 Kanizsa illusory contours is impaired in neurodevelopmental disorders such as schizophrenia, autism, and Williams syndrom
46 ion of dendritic structures accompanies numerous neurologic disorders, such as schizophrenia and autism.
47 indicating potential therapeutic targets for GIN-associated disorders, such as schizophrenia and epilepsy.
49 The results of the work-up for clonal MC disorders such as systemic mastocytosis and monoclonal MC act
50 process, and mutations in these sterol transporters lead to disorders such as Tangier disease and sitosterolemia.